Body Mass Index and Initial Presentations of Cardiovascular Diseases
CALIBER
1 other identifier
observational
2,240,000
1 country
1
Brief Summary
The association between obesity and cardiovascular disease (CVD) has mostly been studied using broad endpoints or have focused on cause-specific mortality. The investigators aim to compare the effect of body mass index (BMI) on different types of initial presentation of CVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 8, 2012
CompletedFirst Posted
Study publicly available on registry
October 11, 2012
CompletedOctober 11, 2012
October 1, 2012
9.2 years
October 8, 2012
October 10, 2012
Conditions
Keywords
Study Arms (1)
CALIBER Healthy Cohort
We will report findings from the CALIBER (CArdiovascular disease research using Linked BEspoke studies and Electronic Records) collaboration where we linked primary care data (from the General Practice Research Database \[GPRD\]) to three further sources of electronic health records: the Myocardial Ischemia National Audit Project registry (MINAP),cause specific discharge data from Hospital Episodes Statistics (HES) and cause specific mortality from the Office for National Statistics (ONS).
Eligibility Criteria
The cohort we will use in the present analysis has been drawn from patients across 225 practices in England contributing data to GPRD, covering approximately 5% of the UK population (Figure 1). The study period is 1st January 2001 to 25th March 2010 (the date of the last GPRD data submission). To allow time for medical history and risk factors to be measured and recorded we require that patients enter the cohort after having completed at least 1 year of registration with their current practice during which the practice provides data that meet research quality criteria. Patients are followed up from the date they become eligible to be included in the cohort until the earliest date among a) the date of an initial presentation with one of the endpoints of interest, b) the date of leaving the practice or c) the date of last data submission from their practice.
You may qualify if:
- Baseline age ≥30 years
You may not qualify if:
- prior atherosclerotic disease or stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University College London
London, WC1E 6BT, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Harry Hemingway, FRCP
Study Record Dates
First Submitted
October 8, 2012
First Posted
October 11, 2012
Study Start
January 1, 2001
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
October 11, 2012
Record last verified: 2012-10